IP Library › Assignment 038137/0906
Patent Assignment
Reel/Frame 038137/0906

Assignment of Assignor's Interest

Recorded: 2016-03-30 Pages: 11
Assignor
BIOMARIN PHARMACEUTICAL INC.
Executed: 2015-10-06
Assignee
MEDIVATION, INC.
525 MARKET STREET, 36TH FLOOR, SAN FRANCISCO, CALIFORNIA, 94105
Covered Properties (20)
Dihydropyridophthalazinone Inhibitors of Poly(Adp-Ribose)Polymerase (Parp)
Patent: 8,012,976 →
Application: 12/510,096 →
Publication: US 2010/0035883
Dihydropyridophthalazinone Inhibitors of Poly(Adp-Ribose)Polymerase (Parp) for Use in Treatment of Diseases Associated with a Pten Deficiency
Patent: 8,541,403 →
Application: 13/020,619 →
Publication: US 2011/0190288
Processes of Synthesizing Dihydropyridophthalazinone Derivatives
Patent: 8,765,945 →
Application: 13/023,140 →
Publication: US 2011/0196153
Dihydropyridophthalazinone Inhibitors of Poly(Adp-Ribose)Polymerase (Parp)
Patent: 8,420,650 →
Application: 13/077,785 →
Publication: US 2011/0237581
Crystalline (8S,9R)-5-Fluoro-8-(4-Fluorophenyl)-9-(1-Methyl-1H-1,2,4-Triazol-5-Yl)-8,9-Dihydro-2H-Pyrido[4,3,2-De]Phthalazin-3(7H)-One Tosylate Salt
Patent: 8,735,392 →
Application: 13/277,607 →
Publication: US 2012/0129865
Dihydropyridophthalazinone Inhibitors of Poly(Adp-Ribose)Polymerase (Parp)
Patent: 8,999,987 →
Application: 13/787,496 →
Publication: US 2013/0190306
Dihydropyridophthalazinone Inhibitors of Poly(Adp-Ribose)Polymerase (Parp) for Use in Treatment of Diseases Associated with a Pten Deficiency
Patent: 9,018,201 →
Application: 13/972,166 →
Publication: US 2014/0066429
Crystalline (8S,9R)-5-Fluoro-8-(4-Fluorophenyl)-9-(1-Methyl-1H-1,2,4-Triazol-5-Yl)-8,9-Dihydro-2H-Pyrido[4,3,2-De]Phthalazin-3(7H)-One Tosylate Salt
Application: 14/252,668 →
Publication: US 2014/0228369
Processes of Synthesizing Dihydropyridophthalazinone Derivatives
Patent: 9,926,303 →
Application: 14/293,642 →
Publication: US 2014/0323725
Dihydropyridophthalazinone Inhibitors of Poly(Adp-Ribose)Polymerase (Parp)
Patent: 9,820,985 →
Application: 14/632,825 →
Publication: US 2015/0209357
Dihydropyridophthalazinone Inhibitors of Poly(Adp-Ribose)Polymerase (Parp) for Use in Treatment of Diseases Associated with a Pten Deficiency
Application: 14/671,944 →
Publication: US 2015/0209363
Dihydropyridophthalazinone Inhibitors of Poly(Adp-Ribose)Polymerase (Parp)
Application: 61/086,687 →
Dihydropyridophthalazinone Inhibitors of Poly(Adp-Ribose)Polymerase (Parp)
Application: 61/151,036 →
Dihydropyridophthalazinone Inhibitors of Poly(Adp-Ribose)Polymerase (Parp)
Application: 61/173,088 →
Dihydropyridophthalazinone Inhibitors of Poly(Adp-Ribose)Polymerase (Parp) for Use in Treatment of Diseases Associated with a Pten Deficiency
Application: 61/301,174 →
Processes of Synthesizing Dihydropyridophthalazinone Derivatives
Application: 61/302,457 →
Dihydropyridophthalazinone Inhibors of Poly(ADP-ribose)polymerase (PARP)
Application: 61/325,126 →
Crystalline (8S,9R)-5-Fluoro-8-(4-Fluorophenyl)-9-(1-Methyl-1H-1,2,4-Triazol-5-Yl)-8,9-Dihydro-2H-Pyrido[4,3,2-De]Phthalazin-3(7H)-One Tosylate Salt
Application: 61/405,476 →
Triazole Intermediates Useful in the Synthesis of Protected N-Alkyltriazolecarbaldehydes
Application: 61/901,300 →
Coformer Salts of (2S,3S)-Methyl 7-Fluoro-2-(4-Fluorophenyl)-3-(1-Methyl-1H-1,2,4-Triazol-5-Yl)-4-Oxo-1,2,3,4-Tetrahydroquinoline-5-Carboxylate and Methods of Preparing Them
Application: 62/031,521 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 20, 2008
From: WANG, BING; CHU, DANIEL
To: LEAD THERAPEUTICS, INC.
Reel/Frame 021414/0927 →
Assignment of Assignor's Interest Feb 26, 2009
From: WANG, BING; CHU, DANIEL
To: LEAD THERAPEUTICS, INC.
Reel/Frame 022316/0282 →
Assignment of Assignor's Interest May 21, 2009
From: WANG, BING; CHU, DANIEL
To: LEAD THERAPEUTICS, INC.
Reel/Frame 022718/0843 →
Assignment of Assignor's Interest Aug 17, 2009
From: WANG, BING; CHU, DANIEL
To: LEAD THERAPEUTICS, INC.
Reel/Frame 023105/0880 →
Assignment of Assignor's Interest Oct 20, 2010
From: WANG, BING; CHU, DANIEL; LIU, YONGBO; JIANG, QUAN
To: BIOMARIN PHARMACEUTICAL INC
Reel/Frame 025168/0650 →
Assignment of Assignor's Interest Oct 20, 2010
From: WANG, BING
To: BIOMARIN PHARMACEUTICAL INC
Reel/Frame 025168/0745 →
Corrective Assignment to Correct the Missing Inventor Name Previously Recorded on Reel 025168 Frame 0745. Assignor(S) Hereby Confirms the Assignment. Oct 26, 2010
From: WANG, BING; CHU, DANIEL
To: BIOMARIN PHARMACEUTICAL INC
Reel/Frame 025195/0130 →
Assignment of Assignor's Interest Jan 3, 2011
From: LEAD THERAPEUTICS, INC.
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 025765/0990 →
Assignment of Assignor's Interest Jan 10, 2011
From: CHU, DANIEL; WANG, BING; FENG, YING; SHEN, YUQIAO
To: LEAD THERAPEUTICS, INC.
Reel/Frame 025774/0025 →
Assignment of Assignor's Interest Jan 10, 2011
From: POST, LEONARD EDWIN
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 025766/0081 →
Corrective Assignment to Correct the Assignee from Biomarin Pharmaceutical Inc. to Lead Therapeutics,Inc. Previously Recorded on Reel 025168 Frame 0650. Assignor(S) Hereby Confirms the Assignment. Jan 11, 2011
From: WANG, BING; CHU, DANIEL; LIU, YONGBO; JIANG, QUAN
To: LEAD THERAPEUTICS, INC.
Reel/Frame 025764/0684 →
Corrective Assignment to Correct the Assignee from Biomarin Pharmaceutical Inc. to Lead Therapeutics, Inc. Previously Recorded on Reel 025195 Frame 0130. Assignor(S) Hereby Confirms the Assignment. Jan 25, 2011
From: WANG, BING; CHU, DANIEL
To: LEAD THERAPEUTICS, INC.
Reel/Frame 025691/0346 →
Assignment of Assignor's Interest Feb 1, 2011
From: LEAD THERAPEUTICS, INC.
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 025728/0451 →
Assignment of Assignor's Interest Mar 24, 2011
From: WANG, BING; CHU, DANIEL; LIU, YONGBO; JIANG, QUAN
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 026018/0799 →
Assignment of Assignor's Interest Apr 8, 2011
From: CHU, DANIEL; WANG, BING; FENG, YING; SHEN, YUQIAO
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 026098/0422 →
Assignment of Assignor's Interest Oct 14, 2011
From: WANG, BING; CHU, DANIEL
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 027062/0951 →
Assignment of Assignor's Interest Feb 10, 2012
From: WANG, BING; LIU, YONGBO; PENG, SHICHUN; CHU, DANIEL
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 027688/0432 →
Assignment of Assignor's Interest Apr 13, 2012
From: WANG, BING; CHU, DANIEL
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 028046/0744 →
Assignment of Assignor's Interest Sep 26, 2013
From: WANG, BING; CHU, DANIEL
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 031287/0129 →
Assignment of Assignor's Interest May 7, 2014
From: HENDERSON, MARK
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 032843/0662 →
Assignment of Assignor's Interest Aug 20, 2014
From: HENDERSON, MARK
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 033576/0233 →
Corrective Assignment to Correct the Missing Inventor Name Previously Recorded at Reel: 033576 Frame: 0233. Assignor(S) Hereby Confirms the Assignment. Aug 22, 2014
From: HENDERSON, MARK; CAMPBELL, COLM
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 033591/0599 →
Assignment of Assignor's Interest Apr 21, 2015
From: WANG, BING; CHU, DANIEL; LIU, YONGBO
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 035462/0217 →
Assignment of Assignor's Interest Apr 21, 2015
From: WANG, BING; CHU, DANIEL
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 035461/0970 →
Security Interest Oct 23, 2015
From: MEDIVATION, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036866/0635 →